Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
NARANJO ARANGO, Yonatan Andrés; GARCIA HENAO, Juan Pablo; FARFAN CORTES, Abraham Yamit Amin Ariff and ALVAREZ CORREA, Daniela. Guillain-Barré syndrome as an autoimmune neurological manifestation associated with COVID-19: A review of the literature. Rev.Colomb.Reumatol. [online]. 2022, vol.29, suppl.1, pp.48-55. Epub Feb 02, 2024. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2021.01.004.
The coronavirus disease (COVID-19) caused by SARS-CoV-2 has been a challenge for health services around the world. The pandemic has spread widely, with more than 80 million confirmed cases and more than one million deaths globally. There have been many studies to understand all aspects of the disease. Recently, several cases have been reported of patients with Guillain-Barré syndrome associated with COVID-19 as the main manifestation.
As it may be one of the first autoimmune neurological diseases triggered by SARS-CoV-2, it is necessary to obtain more information to fully understand the immunopathogenic mechanisms involved in this association.
Keywords : Coronavirus; COVID-19; Guillain-Barré syndrome; Rheumatic diseases.